The role of monoamines in rotation induced or potentiated by amphetamine after nigral, raphe and mesencephalic reticular lesions in the rat brain.
D000588:Amines / Q000378:metabolism*; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal; D001921:Brain / Q000378:metabolism; D001930:Brain Injuries / Q000503:physiopathology*; D002375:Catalepsy / Q000139:chemically induced; D002540:Cerebral Cortex / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D010134:Fenclonine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D008297:Male; D008636:Mesencephalon / Q000293:injuries*; D008781:Methyltyrosines / Q000494:pharmacology; D009043:Motor Activity; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012154:Reticular Formation / Q000293:injuries*; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology; D013378:Substantia Nigra / Q000293:injuries*
D000588:Amines; D008781:Methyltyrosines; D012701:Serotonin; D000661:Amphetamine; D006220:Haloperidol; D010134:Fenclonine; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine